US President Trump has warned that the US administration may soon address “very unfair” trade with the European Union.
“I’ve had a lot of problems with the European Union, and it may morph into something very big from … a trade standpoint,” Trump said in an interview with British broadcaster ITV on Sunday, January 28.
“It’s a very unfair situation,” he added. “We cannot get our product in. It’s very, very tough, and yet they send their product to us—no taxes, very little taxes.”
Trump has on several occasions criticized the EU over trade, singling out export powerhouse Germany for running a big trade deficit with the United States.
The rhetoric has not yet translated into substantial action, but the Trump administration’s efforts to crack down on what it perceives as unfair trade now appear to be gaining momentum.
The EU said Monday that trade policy is “not about winners and losers.”
“The European Union stands ready to act swiftly and appropriately in case our exports are affected by any restrictive trade measures from the United States,” said European Commission spokesman Margaritis Schinas.
Full Content: Bloomberg
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Top Antitrust Expert Joins Cravath from Paul Weiss
Jan 21, 2025 by
CPI
CMA Chief Removed as UK Government Targets Regulatory Overhaul
Jan 21, 2025 by
CPI
Court Denies Dismissal in Crab Price-Fixing Lawsuit
Jan 21, 2025 by
CPI
TikTok Stays Online for Now: Trump Floats US Ownership Deal
Jan 21, 2025 by
CPI
Hong Kong Watchdog Unveils Compliance Tool for Small Businesses
Jan 21, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Pharmacy Benefit Managers
Jan 20, 2025 by
CPI
Untangling the PBM Mess
Jan 20, 2025 by
Kent Bernard
Using Data, Not Anecdotes, to Analyze Criticisms of Pharmacy Benefit Managers
Jan 20, 2025 by
Dennis Carlton
Vertical Integration and PBMs: What, Me Worry?
Jan 20, 2025 by
Lawton Robert Burns & Bradley Fluegel
The Economics of Benefit Management in Prescription-Drug Markets
Jan 20, 2025 by
Casey B. Mulligan